Navigation Links
Velos to Develop Key System Interface for Clinical Research
Date:3/26/2008

- Will facilitate tight integration between sponsors and investigators -

FREMONT, Calif., March 26 /PRNewswire/ -- Velos, Inc., a recognized leader and trusted resource for clinical trial management information systems and member of the Oracle PartnerNetwork, will work to develop a key interface between Velos eResearch and Oracle Clinical. Both software products serve to advance clinical research. Velos eResearch is widely installed at research sites, while Oracle Clinical holds a leadership position among research sponsors.

When complete, Oracle Clinical customers should be able to populate Velos eResearch with content, such as research protocols, case reports and data dictionaries, which will then be used by Velos sites for study fulfillment. Velos eResearch customers should then be able to return study information collected through eResearch to Oracle Clinical where it can be integrated and analyzed together with information collected from other sources. This two-way system handshake will help to ensure consistency, greatly reduce redundant data entry and foster other systematic efficiencies that will enable higher quality, more timely clinical research fulfillment for sponsors and investigators alike.

"Oracle Clinical customers have expressed the desire to interoperate with systems used at research sites," said Neil de Crescenzo, Group Vice President, Healthcare and Life Sciences, Oracle. "Velos is a clear leader among clinical trial management systems used at research sites in the U.S., particularly among larger academic medical centers. We welcome their plan to develop an interface between Velos eResearch and Oracle Clinical."

Velos eResearch is deployed by 21 top 25 academic medical centers and research institutions named in the U.S. News & World Report, 2007 Best Hospitals Survey. In the same survey, 14 of the 18 institutions receiving "Honor Roll" status are Velos customers. Approximately 30 percent of all NIH (National Inst
'/>"/>

SOURCE Velos, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
2. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
3. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
7. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
8. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
9. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
10. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
11. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
(Date:12/3/2009)DURHAM, N.C., Dec. 3 In response to the increasingly critical role of healthcare information technologies in the evolving healthcare delivery system, Duke Medicine has created the Duke Center for Hea
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Study shows promise for new cancer stopping therapy 48649 1Study shows promise for new cancer stopping therapy 48649 2Brown 26 Toland Announces 2008 Financial Results 48645 1Brown 26 Toland Announces 2008 Financial Results 48645 2Carrier Increases Energy Efficiency at Hartford Hospital 48640 1Carrier Increases Energy Efficiency at Hartford Hospital 48640 2Carrier Increases Energy Efficiency at Hartford Hospital 48640 3
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
...saster Giving Program Provide,Financial Support, ...ripped through the South Tuesday night resulting i...entucky, Tennessee, Alabama and,Mississippi. The t...and search and rescue workers, and lending,emotion...
...)Perhaps the only positive spin one can put on the...uncommon. Other than that, the news is bad. It is ...the prime of their lives, and the limited treatmen... of cancer. , One approach focuses on a gene cal...
...dation of,America (LFA) is proud to unveil new pub...Five new booklets and eleven fact sheets provide t...diagnosis and treatment., The publications featur.... Developed in consultation with the nation,s,lead...
...application of high throughput DNA sequencing tec...eak, scientists from Columbia University Mailman S...iseases Reference Laboratory (VIRDL) in Melbourne,...who received organs from a single donor in Victori...
...and Net Income in Company History, BELLEVUE, Wash... leading online provider of health, beauty, vision...cial results for the fourth,quarter and fiscal yea...eved record gross margins in the fourth quarter,of...
...n Home Resident regain mobility and,Be Active, NE...a "sweetheart with a sweet tooth" say his friends ...ison wore out a borrowed power wheelchair,from del...COOTER Store has donated a new power wheelchair to...
Other Medicine News:Health News:American Red Cross Responds to Tornadoes in the Southeast 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:Lupus Foundation of America Releases New Patient Education Series 2Health News:Scientists confirm new virus responsible for deaths of transplant recipients in Australia 2Health News:Scientists confirm new virus responsible for deaths of transplant recipients in Australia 3Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 2Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 3Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 4Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 5Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 6Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 7Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 8Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 9Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 10Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 11Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 12Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 13Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 14Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 15Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 16Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 17Health News:The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim 2
...'s CODA® Automated EIA Analyzer is an exceptio...x microplate-based assays. The system's programmin...y laboratories. For low volume users, the software...with common features to complete 9 assays simultan...
...rent available techniques for prenatal diagnosis (... their use a small but significant chance of misca...ers invasive prenatal baby gender testing only to ...bnormalities are greater than or equal to the risk...
...SH pharmDx Kit is a direct fluorescence in situ hy...y determine HER2 gene amplification in formalin-fi...ens. Gene amplification is determined from the rat...ation of the HER2 gene probe (red signals) and the...
...ors in Anesthesia and Respiratory Products, ,West...lity medical devices for Anesthesia and Respirator...facture products that enhance the clinician's abil...lose attention to the bottom line. , ,Our web sit...
Medicine Products: